BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1813075)

  • 1. Effect of a single oral dose of metrifonate on human plasma cholinesterase levels.
    Nhachi CF; Murambiwa W; Kasilo OJ; Gwanzura L; Mason P
    Bull Environ Contam Toxicol; 1991 Nov; 47(5):641-5. PubMed ID: 1813075
    [No Abstract]   [Full Text] [Related]  

  • 2. Metrifonate and dichlorvos: effects of a single oral administration on cholinesterase activity in rat brain and blood.
    Hinz V; Grewig S; Schmidt BH
    Neurochem Res; 1996 Mar; 21(3):339-45. PubMed ID: 9139240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metrifonate in healthy volunteers: interrelationship between pharmacokinetic properties, cholinesterase inhibition and side-effects.
    Aden-Abdi Y; Villén T; Ericsson O; Gustafsson LL; Dahl-Puustinen ML
    Bull World Health Organ; 1990; 68(6):731-6. PubMed ID: 2073711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of metrifonate on blood cholinesterases in children during the treatment of schistosomiasis.
    Davis RP; Bailey DR
    Bull World Health Organ; 1972; 46(6):747-59. PubMed ID: 4538536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypolipidemic effect of metrifonate and the relationship to serum cholinesterase inhibition.
    Udom CE; Smith TJ
    Res Commun Chem Pathol Pharmacol; 1991 Mar; 71(3):387-90. PubMed ID: 2047580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of metrifonate on neuromuscular transmission.
    Le Quesne PM; Maxwell IC
    Acta Pharmacol Toxicol (Copenh); 1981; 49 Suppl 5():99-104. PubMed ID: 6283788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metrifonate treatment enhances acquisition of eyeblink conditioning in aging rabbits.
    Kronforst-Collins MA; Moriearty PL; Ralph M; Becker RE; Schmidt B; Thompson LT; Disterhoft JF
    Pharmacol Biochem Behav; 1997 Jan; 56(1):103-10. PubMed ID: 8981616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect on neuromuscular transmission of repeated administration of an organophosphorus compound, metrifonate, during treatment of children with urinary schistosomiasis.
    Maxwell IC; Le Quesne PM; Ekue JM; Biles JE
    Neurotoxicology; 1981 Dec; 2(4):687-701. PubMed ID: 6281697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The cholinesterase activity of red blood cells and plasma after cutaneous or oral application of metrifonatum NFN in pigs].
    Karlog O; Rasmussen F; Skafte B
    Nord Vet Med; 1971 Mar; 23(3):170-5. PubMed ID: 5140307
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition by metrifonate and dichlorvos of cholinesterases in schistosomes.
    Bueding E; Liu CL; Rogers SH
    Br J Pharmacol; 1972 Nov; 46(3):480-7. PubMed ID: 4656609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of subchronic treatment with metrifonate and tacrine on brain cholinergic function in aged F344 rats.
    Giovannini MG; Scali C; Bartolini L; Schmidt B; Pepeu G
    Eur J Pharmacol; 1998 Jul; 354(1):17-24. PubMed ID: 9726626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of metrifonate on extracellular brain acetylcholine and object recognition in aged rats.
    Scali C; Giovannini MG; Bartolini L; Prosperi C; Hinz V; Schmidt B; Pepeu G
    Eur J Pharmacol; 1997 May; 325(2-3):173-80. PubMed ID: 9163564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of brain cholinesterase inhibition following metrifonate administration.
    Dachir S; Schmidt BH; Levy A
    Neurochem Res; 1999 Aug; 24(8):1075-80. PubMed ID: 10478948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of metrifonate in humans.
    Unni LK; Womack C; Hannant ME; Becker RE
    Methods Find Exp Clin Pharmacol; 1994 May; 16(4):285-9. PubMed ID: 8051989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single dose metrifonate in the treatment of urinary schistosomiasis in an area of low prevalence and intensity of infection.
    Tswana SA; Mason PR
    Cent Afr J Med; 1986 Jun; 32(6):133-7. PubMed ID: 3105891
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor metrifonate in patients with renal impairment.
    Dingemanse J; Halabi A; Kleinbloesem CH; Heinig R; Blume H
    Ther Drug Monit; 1999 Jun; 21(3):310-6. PubMed ID: 10365643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical toxicosis and erythrocyte cholinesterase inhibition of trichlorfon combined with mebendazole in horses.
    Gingerich DA; Mia AS
    Am J Vet Res; 1981 Sep; 42(9):1645-50. PubMed ID: 7325477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of food and time of administration on the pharmacokinetic and pharmacodynamic profile of metrifonate.
    Heinig R; Sachse R
    Int J Clin Pharmacol Ther; 1999 Sep; 37(9):456-64. PubMed ID: 10507245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of metrifonate and dichlorvos in plasma and erythrocytes during treatment of schistosomiasis with Bilarcil.
    Nordgren I; Bengtsson E; Holmstedt B; Pettersson BM
    Acta Pharmacol Toxicol (Copenh); 1981; 49 Suppl 5():79-86. PubMed ID: 7344416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of subchronic metrifonate treatment on cerebral glucose metabolism in young and aged rats.
    Poindessous-Jazat F; Schmidt BH; Bassant MH
    Eur J Pharmacol; 1998 Dec; 363(1):17-28. PubMed ID: 9877077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.